WJ-150 — Wharton’s Jelly · High Density Matrix
Wharton’s jelly is the connective tissue matrix of the human umbilical cord — rich in hyaluronic acid, collagen, proteoglycans, and the structural proteins that define connective tissue architecture. Where exosomes restore biological signalling, Wharton’s jelly restores the structural environment in which that signalling is received and expressed. It rebuilds the extracellular matrix — the physical foundation that cellular activity depends on.
WJ-150 is the high density Wharton’s jelly formulation. At 150mg in a concentrated 1mL frozen format it is designed for precise targeted placement in structural joint applications — where both the volume and density of the matrix restoration matter to the clinical outcome.
WJ-150 is paired with EXO-180 for the structural joint signalling protocol — the highest concentration Wharton’s jelly targeted placement combined with the apex endothelial systemic signalling formulation. Addressing both the structural degradation of the joint environment and the advanced vascular and tissue repair signalling required for meaningful regenerative outcomes.
Specifications
Concentration: 150mg · Volume: 1mL · Format: Frozen · Source: Human Umbilical Cord · Access: Clinical Only
Manufactured by Platinum Biologics. US donors. Full pathogen screening. COA on every batch.